Blue Jet Healthcare · NSE: BLUEJET · BSE: 544009
Q4 FY26 results · Jan–Mar 2026
Blue Jet Healthcare reported revenue from operations of ₹234.67 crore (down 31.1% from Q4 FY25) and net profit of ₹64.34 crore (down 41.6% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a standalone basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 234.67 | 340.44 | −31.1% | 192.41 | +22.0% |
| Other income | 22.92 | 12.22 | +87.5% | 13.21 | +73.5% |
| Total income | 257.59 | 352.67 | −27.0% | 205.62 | +25.3% |
| Profit before tax | 87.15 | 147.21 | −40.8% | 53.78 | +62.1% |
| Net profit for the period | 64.34 | 110.09 | −41.6% | 40.17 | +60.2% |
| EPS, basic (₹) | 3.71 | 6.35 | −41.6% | 2.32 | +59.9% |
| Net margin (%) | 27.4 | 32.3 | 20.9 |
Standalone
- Filed with BSE
- 25 May 2026, 15:58 IST
- Board meeting
- 25 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE